Barometer Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,500
Closed -$539K 112
2022
Q1
$539K Hold
10,500
0.1% 104
2021
Q4
$615K Buy
+10,500
New +$520K 0.1% 98
2021
Q1
Sell
-13,200
Closed -$481K 190
2020
Q4
$481K Buy
+13,200
New +$484K 0.09% 129
2019
Q1
Sell
-384,499
Closed -$15.8M 160
2018
Q4
$15.8M Buy
384,499
+25,928
+7% +$1.08M 3.22% 8
2018
Q3
$15M Buy
+358,571
New +$13.8M 1.17% 26
2015
Q4
Sell
-632
Closed -$19K 147
2015
Q3
$19K Sell
632
-601,097
-100% -$19.3M ﹤0.01% 115
2015
Q2
$19.1M Sell
601,729
-251,168
-29% -$8.19M 1.56% 28
2015
Q1
$28.2M Buy
+852,897
New +$27.1M 2.18% 21
2014
Q2
Sell
-455,644
Closed -$13.9M 128
2014
Q1
$13.9M Buy
+455,644
New +$13.6M 3.02% 11

Other funds holding PFE

Barometer Capital Management's PFE Position: Q2 2022 in Review

Barometer Capital Management sold out of Pfizer (PFE) in Q2 2022, closing a stake of 10,500 shares — an estimated $539K sold.

Barometer Capital Management first reported a position in PFE in Q1 2014 and held it in 9 quarters. The position peaked at $28.2M in Q1 2015. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Barometer Capital Management reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Barometer Capital Management sold 10,500 Pfizer shares in Q2 2022, an estimated $539K.
  • Barometer Capital Management first reported a position in Pfizer in Q1 2014 and held it in 9 quarters.
  • Barometer Capital Management's Pfizer position peaked at $28.2M in Q1 2015.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Barometer Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.